References

References

1. England – GP Prescribing Data, https://opendata.nhsbsa.net/dataset/english-prescribing-data-epd, Accessed – January 2023.
Welsh – GP Prescribing Data, https://nwssp.nhs.wales/ourservices/primary-care-services/general-information/data-and-publications/general-practice-prescribing-data-extract/, Accessed – January 2023.
Northern Ireland – GP Prescribing Data, https://www.opendatani.gov.uk/dataset/gp-prescribing-data, Accessed – January 2023.
Scotland – Prescribing Data, https://www.opendata.nhs.scot/dataset/prescriptions-in-the-community, Accessed – January 2023.

2. Drug Tariff – England & Wales, accessed June 2023

3. MIMS – June 2023 edition

4. Oxeltra SmPC available at
https://www.medicines.org.uk/emc/product/8900/smpc#POSOLOGY Accessed Jan 23

5. Wockhardt UK Data on file – OxeltBio1

*Longtec® is a registered Trademark of Mundipharm AG, Switzerland

YOUR COST
SAVINGS PARTNER.

Oxeltra® PR tablets are part of Wockhardt UK’s bioequivalent brands portfolio

  • Helping to maximise Primary Care Budgets
  • Expanding portfolio in multiple therapy areas
  • Extended Oxycodone hydrochloride range – also available as an Oral Solution & Solution for injection

Adverse events should be reported. Reporting forms and information can be found at: https://yellowcard.mhra.gov.uk/

Adverse events should also be reported to Wockhardt UK. Please contact us or email us at drug.safety@wockhardt.co.uk